North America Urinalysis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Consumables and Instruments), Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis), Application (Disease Screening and Pregnancy and Fertility), and End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories, and Institutes)
Market Introduction
The North America Urinalysis market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North America Urinalysis market. The growth can be attributed to increase in the prevalence of chronic diseases, presence of key market players and extensive R&D conducted by various research laboratories and institutes. In addition, there is also a boom in public healthcare expenditure and an increase in the awareness programs that are further expected to stimulate the growth of the urinalysis market.
Lockdowns enacted by various North American countries to control the spread of COVID-19 caused people to delay undergoing health checkups, thus affecting the number of tests performed and sales of instruments, consumables, and reagents. However, a resurgence in testing numbers is seen as countries gradually ease the restrictions imposed on movement. According to National Kidney Foundation, people hospitalized with COVID-19 are at a significant risk of acute kidney injury (AKI), leading to serious illness, dialysis, and death. For the recovered COVID-19 patients who had an AKI or acute renal failure, urinalysis diagnosis is recommended since the risk of developing chronic kidney disease is higher in them than others. COVID-19 patients who did not develop an AKI, but had blood and/or protein in their urine, need to be monitored as they are at a greater risk of developing chronic- and end-stage kidney disease. COVID-19 has also impacted the regulatory environment and practices, as governments and healthcare providers are facing unprecedented challenges. Regulatory authorities utilized methods to speed approval of diagnostic products. Companies have taken strategic developments to introduce COVID-19 rapid tests, sustain their revenues, and nullify the impact of COVID-19 on their operational capabilities. For instance, in August 2020, Sysmex America, Inc., a leading diagnostic solutions company, entered into a distribution agreement with Siemens Healthineers to increase the distribution of the CLINITEK Novus automated urine chemistry analyzer platform. Therefore, in the long run, upon the streamlining of the COVID-19 vaccination programs and the decrease in transmission rates, healthcare systems will return to normal and generate significant demand urinalysis products and services.
Get more information on this report :
Market Overview and Dynamics
The urinalysis market in North America is expected to grow from US$ 1,432.01 million in 2021 to US$ 2,129.13 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028. The urinalysis market is characterized by the presence of various small and big companies. The market players are adopting the strategies such as new product launches, regional expansions, and technological advancements to expand their market share. Rising demand for rapid tests, point-of-care (PoC) testing, and portable instruments are encouraging new product launches in the urinalysis market. The PoC testing enables rapid results in non-laboratory settings, along with boosting productivity. These tests are cost-effective and encompass the diagnoses of a wide range of diseases. Moreover, the growing demand for PoC diagnostics products is further driving product innovations in the urinalysis market. Market players are readily investing in R&D to develop advanced technologies.
Key Market Segments
North America urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the North America urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The North America urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the North America urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The North America urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the North America urinalysis market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the urinalysis market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and Sysmex Corporation.
Reasons to buy report
- To understand the North America urinalysis market landscape and identify market segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America urinalysis market.
- Efficiently plan M&A and partnership deals in North America urinalysis market by identifying market segments with the most promising probable sales.
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America urinalysis market.
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
North America Urinalysis Market Segmentation
North America Urinalysis Market - By Product
- Consumables
- Instruments
North America Urinalysis Market - By Test Type
- Pregnancy and Fertility Tests
- Biochemical Urinalysis
- Sediment Urinalysis
North America Urinalysis Market - By Application
- Disease Screening
- Pregnancy and Fertility
North America Urinalysis Market - By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Research Laboratories and Institutes
North America Urinalysis Market - By Country
- US
- Canada
- Mexico
North America Urinalysis Market - Company Profiles
- Abbott
- ACON Laboratories, Inc.
- ARKRAY, Inc.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories Inc.
- Cardinal Health Inc
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Siemens Healthineers AG
- Sysmex Corporation
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Urinalysis Market – By Product
1.3.2 North America Urinalysis Market – By Test Type
1.3.3 North America Urinalysis Market – By Application
1.3.4 North America Urinalysis Market – By End User
1.3.5 North America Urinalysis Market – By Country
2. North America Urinalysis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Urinalysis Market – Market Landscape
4.1 Overview
4.1.1 North America – PEST Analysis
4.2 Expert Opinions
5. North America Urinalysis Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Cases of Urinary Tract Infection, Diabetes, and Kidney Diseases
5.1.2 Growing Number of Geriatric Population
5.2 Market Restraints
5.2.1 Strict Regulatory Protocols and Product Fails
5.3 Future Trends
5.3.1 Rising Number of Product Developments and Strategic Initiatives by Market Players
5.4 Impact Analysis
6. Urinalysis Market – North America Analysis
6.1 North America Urinalysis Market Revenue Forecast and Analysis
7. North America Urinalysis Market Analysis – By Product
7.1 Overview
7.2 North America Urinalysis Market Share by Products 2021 & 2028 (%)
7.3 Consumable
7.3.1 Overview
7.3.2 Consumables Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecast to 2028 (US$ Mn)
8. North America Urinalysis Market Analysis – By Test Type
8.1 Overview
8.1.1 North America Urinalysis Market, By Test Type 2021 & 2028 (%)
8.2 Pregnancy and Fertility Tests Market
8.2.1 Overview
8.2.2 North America Pregnancy and Fertility Tests Market Revenue and Forecasts to 2028 (US$ Million)
8.3 Biochemical Urinalysis
8.3.1 Overview
8.3.2 North America Biochemical Urinalysis Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Sediment Urinalysis
8.4.1 Overview
8.4.2 North America Sediment Urinalysis Market Revenue and Forecasts to 2028 (US$ Million)
9. North America Urinalysis Market Analysis – By Application
9.1 Overview
9.2 North America Urinalysis Market Share by Application 2021 & 2028 (%)
9.3 Disease Screening
9.3.1 Overview
9.3.2 Disease Screening Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Pregnancy and Fertility
9.4.1 Overview
9.4.2 Pregnancy and Fertility Market Revenue and Forecast to 2028 (US$ Mn)
10. North America Urinalysis Market Analysis – By End User
10.1 Overview
10.2 North America Urinalysis Market Share, by End User, 2021 and 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)
10.5 Home Care Settings
10.5.1 Overview
10.5.2 Home Care Settings: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)
10.6 Research Laboratories and Institutes
10.6.1 Overview
10.6.2 Research Laboratories and Institutes: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)
11. North America Urinalysis Market – Country Analysis
11.1 Overview
11.1.1 North America: Urinalysis Market, by Country, 2021 & 2028 (%)
11.1.1.1 US: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 US: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.2 US Urinalysis Market, by Products – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.3 US: Urinalysis Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.4 US: Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.5 US: Urinalysis Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.1.2 Canada: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 Canada: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.2 Canada Urinalysis Market, by Products – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.3 Canada Urinalysis Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.4 Canada Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.5 Canada Urinalysis Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.1.3 Mexico: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 Mexico: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.2 Mexico Urinalysis Market, by Products – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.3 Mexico Urinalysis Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.4 Mexico Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.5 Mexico Urinalysis Market, by End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on North America Urinalysis Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Urinalysis Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Urinalysis Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ACON Laboratories, Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 ARKRAY, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Beckman Coulter, Inc. (Danaher Corporation Subsidiary)
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Cardinal Health Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 F. HOFFMANN-LA ROCHE LTD.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Quidel Corporation
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Siemens Healthineers AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sysmex Corporation
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. US Urinalysis Market, by Products – Revenue and Forecast to 2028 (USD Million)
Table 2. US Urinalysis Market, by Test Type - Revenue and Forecast to 2028 (USD Million)
Table 3. US Urinalysis Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 4. US Urinalysis Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Urinalysis Market, by Products -Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Urinalysis Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Urinalysis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Urinalysis Market, by Products -Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Urinalysis Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Urinalysis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments in the Urinalysis Market
Table 14. Inorganic Developments in the Urinalysis Market
Table 15. Glossary of Terms, Urinalysis Market
LIST OF FIGURES
Figure 1. North America Urinalysis Market Segmentation
Figure 2. North America Urinalysis Market Segmentation, By Country
Figure 3. North America Urinalysis Market Overview
Figure 4. Consumables Segment Held the Largest Share of the Product Segment in North America Urinalysis Market
Figure 5. US to Show Significant Growth During Forecast Period
Figure 7. North America PEST Analysis
Figure 8. North America Urinalysis Market Impact Analysis of Driver and Restraints
Figure 9. North America Urinalysis Market – Revenue Forecast and Analysis – 2019- 2028
Figure 10. North America Urinalysis Market Share by Products 2021 & 2028 (%)
Figure 11. North America Consumables Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. North America Instruments Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. North America Urinalysis Market, By Test Type 2021 & 2028 (%)
Figure 14. North America Pregnancy and Fertility Tests Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. North America Biochemical Urinalysis Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. North America Sediment Urinalysis Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. North America Urinalysis Market Share by Application 2021 & 2028 (%)
Figure 18. North America Disease Screening Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. North America Pregnancy and Fertility Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Urinalysis Market Share, by End User, 2021 and 2028 (%)
Figure 21. North America Hospitals and Clinics: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Diagnostic Laboratories: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Home Care Settings: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Research Laboratories and Institutes: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America: Urinalysis Market, by Key Country – Revenue (2021) (USD Million)
Figure 26. North America: Urinalysis Market, by Country, 2021 & 2028 (%)
Figure 27. US: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Canada: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Mexico: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Impact of COVID-19 Pandemic on Cardiovascular Needle Market in North American Country Markets
Figure 31. Growth Strategies in the Urinalysis Market (%)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America urinalysis market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America urinalysis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the urinalysis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution